IASLC Names New Chief Science Officer

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

Laura Greco of “Die, Cancer, Die!” Fame will be Remembered for her Passionate Patient Advocacy

Patient Comment on Mobocertinib for Exon 20

Trastuzumab Deruxtecan Potential New Treatment Options for HER2+ NSCLC

Targeting KRAS in Lung Cancer: The Past, Present, and Future 

Mobocertinib May Offer Effective, Safe Treatment in NSCLC with EGFR Exon 20 Insertion Mutation